Skip to main content
Clinical Trials/NL-OMON40828
NL-OMON40828
Withdrawn
Not Applicable

Effects of polyphenol supplementation on inflammation and coronary endothelial function in patients with documented coronary artery disease - PENSIO

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atherosclerosis
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • 18 years or older
  • \& scheduled for CAG/PCI for stable angina pectoris
  • \& with documentation of an abnormal peripheral FMD\-measurement
  • \& with signed informed consent.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Patients with unstable angina, vasospastic angina pectoris, recent myocardial infarction, valvular heart disease, clinical evidence of heart failure, left ventricular hypertrophy, uncontrolled hypertension, peripheral vascular disease, LVEF \<50%, and/or significant endocrine, hepatic, renal, or inflammatory disease are excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials